|
|
Volumn 44, Issue 4, 1999, Pages 747-748
|
|
What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
BEAM THERAPY;
BRACHYTHERAPY;
CANCER CELL;
CELL CYCLE G0 PHASE;
CELL CYCLE G2 PHASE;
CELL POPULATION;
CELL PROLIFERATION;
EDITORIAL;
HUMAN;
LINEAR ENERGY TRANSFER;
MALE;
PRIORITY JOURNAL;
PROSTATE CANCER;
RADIATION INJURY;
RADIATION RESPONSE;
TREATMENT OUTCOME;
BRACHYTHERAPY;
CELL DIVISION;
CELL SURVIVAL;
DOSE FRACTIONATION;
HUMANS;
INTERPHASE;
MALE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
|
|
EID: 0033026882
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/S0360-3016(99)00024-3 Document Type: Editorial |
|
Times cited : (189)
|
|
References (14)
|
